nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—breast cancer	0.763	1	CbGaD
Framycetin—CXCR4—mammary gland—breast cancer	0.00732	0.141	CbGeAlD
Framycetin—CXCR4—nipple—breast cancer	0.00605	0.116	CbGeAlD
Framycetin—CXCR4—embryo—breast cancer	0.005	0.0961	CbGeAlD
Framycetin—CXCR4—epithelium—breast cancer	0.00408	0.0784	CbGeAlD
Framycetin—CXCR4—endometrium—breast cancer	0.00366	0.0703	CbGeAlD
Framycetin—Ototoxicity—Vinorelbine—breast cancer	0.00361	0.0455	CcSEcCtD
Framycetin—Ototoxicity—Thiotepa—breast cancer	0.00345	0.0435	CcSEcCtD
Framycetin—CXCR4—uterus—breast cancer	0.00337	0.0648	CbGeAlD
Framycetin—CXCR4—pituitary gland—breast cancer	0.00331	0.0636	CbGeAlD
Framycetin—CXCR4—adipose tissue—breast cancer	0.00329	0.0634	CbGeAlD
Framycetin—CXCR4—female reproductive system—breast cancer	0.00303	0.0582	CbGeAlD
Framycetin—CXCR4—adrenal gland—breast cancer	0.00296	0.0568	CbGeAlD
Framycetin—CXCR4—bone marrow—breast cancer	0.00286	0.055	CbGeAlD
Framycetin—CXCR4—female gonad—breast cancer	0.00276	0.053	CbGeAlD
Framycetin—CXCR4—endocrine gland—breast cancer	0.00256	0.0493	CbGeAlD
Framycetin—Ototoxicity—Paclitaxel—breast cancer	0.00243	0.0306	CcSEcCtD
Framycetin—Nerve injury—Paclitaxel—breast cancer	0.00223	0.0281	CcSEcCtD
Framycetin—Glaucoma—Toremifene—breast cancer	0.0021	0.0265	CcSEcCtD
Framycetin—Ototoxicity—Docetaxel—breast cancer	0.00206	0.026	CcSEcCtD
Framycetin—Malabsorption—Methotrexate—breast cancer	0.00205	0.0259	CcSEcCtD
Framycetin—Impaired healing—Melphalan—breast cancer	0.00192	0.0242	CcSEcCtD
Framycetin—CXCR4—lymph node—breast cancer	0.00177	0.0341	CbGeAlD
Framycetin—Viral infection—Exemestane—breast cancer	0.00154	0.0194	CcSEcCtD
Framycetin—Viral infection—Letrozole—breast cancer	0.00137	0.0173	CcSEcCtD
Framycetin—Nephropathy toxic—Vinorelbine—breast cancer	0.00126	0.0159	CcSEcCtD
Framycetin—Nephropathy toxic—Mitoxantrone—breast cancer	0.00104	0.0131	CcSEcCtD
Framycetin—Swelling—Anastrozole—breast cancer	0.00102	0.0128	CcSEcCtD
Framycetin—Nephropathy toxic—Gemcitabine—breast cancer	0.00101	0.0128	CcSEcCtD
Framycetin—Secondary infection—Epirubicin—breast cancer	0.000948	0.012	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—breast cancer	0.000877	0.0111	CcSEcCtD
Framycetin—Anaphylactic shock—Fluoxymesterone—breast cancer	0.000877	0.0111	CcSEcCtD
Framycetin—Nephropathy toxic—Paclitaxel—breast cancer	0.000849	0.0107	CcSEcCtD
Framycetin—Sensitisation—Epirubicin—breast cancer	0.00078	0.00984	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—breast cancer	0.000722	0.0091	CcSEcCtD
Framycetin—Swelling—Tamoxifen—breast cancer	0.000697	0.00879	CcSEcCtD
Framycetin—Impaired healing—Methotrexate—breast cancer	0.000689	0.00868	CcSEcCtD
Framycetin—Swelling—Goserelin—breast cancer	0.000666	0.00839	CcSEcCtD
Framycetin—Viral infection—Mitoxantrone—breast cancer	0.000662	0.00834	CcSEcCtD
Framycetin—Infection—Carboplatin—breast cancer	0.000656	0.00827	CcSEcCtD
Framycetin—Hypersensitivity—Fluoxymesterone—breast cancer	0.000646	0.00814	CcSEcCtD
Framycetin—Anaphylactic shock—Lapatinib—breast cancer	0.000622	0.00785	CcSEcCtD
Framycetin—Infection—Lapatinib—breast cancer	0.000618	0.00779	CcSEcCtD
Framycetin—Infection—Fulvestrant—breast cancer	0.000569	0.00717	CcSEcCtD
Framycetin—Erythema—Anastrozole—breast cancer	0.000541	0.00682	CcSEcCtD
Framycetin—Viral infection—Paclitaxel—breast cancer	0.00054	0.0068	CcSEcCtD
Framycetin—Nausea—Fluoxymesterone—breast cancer	0.000521	0.00656	CcSEcCtD
Framycetin—Infection—Exemestane—breast cancer	0.000494	0.00623	CcSEcCtD
Framycetin—Swelling—Mitoxantrone—breast cancer	0.000492	0.0062	CcSEcCtD
Framycetin—Swelling—Fluorouracil—breast cancer	0.000471	0.00594	CcSEcCtD
Framycetin—Infection—Ixabepilone—breast cancer	0.000466	0.00587	CcSEcCtD
Framycetin—Hypersensitivity—Lapatinib—breast cancer	0.000458	0.00578	CcSEcCtD
Framycetin—Anaphylactic shock—Letrozole—breast cancer	0.000442	0.00557	CcSEcCtD
Framycetin—Anaphylactic shock—Anastrozole—breast cancer	0.000442	0.00557	CcSEcCtD
Framycetin—Pruritus—Lapatinib—breast cancer	0.00044	0.00555	CcSEcCtD
Framycetin—Infection—Letrozole—breast cancer	0.000439	0.00553	CcSEcCtD
Framycetin—Infection—Anastrozole—breast cancer	0.000439	0.00553	CcSEcCtD
Framycetin—Diarrhoea—Lapatinib—breast cancer	0.000426	0.00537	CcSEcCtD
Framycetin—Hypersensitivity—Fulvestrant—breast cancer	0.000422	0.00532	CcSEcCtD
Framycetin—Anaphylactic shock—Idarubicin—breast cancer	0.000419	0.00528	CcSEcCtD
Framycetin—Infection—Idarubicin—breast cancer	0.000416	0.00525	CcSEcCtD
Framycetin—Infection—Raloxifene—breast cancer	0.000416	0.00525	CcSEcCtD
Framycetin—Pruritus—Fulvestrant—breast cancer	0.000405	0.0051	CcSEcCtD
Framycetin—Swelling—Paclitaxel—breast cancer	0.000401	0.00506	CcSEcCtD
Framycetin—Pruritus—Toremifene—breast cancer	0.0004	0.00504	CcSEcCtD
Framycetin—Vomiting—Lapatinib—breast cancer	0.000396	0.00499	CcSEcCtD
Framycetin—Diarrhoea—Fulvestrant—breast cancer	0.000392	0.00494	CcSEcCtD
Framycetin—Erythema—Tamoxifen—breast cancer	0.00037	0.00467	CcSEcCtD
Framycetin—Nausea—Lapatinib—breast cancer	0.00037	0.00466	CcSEcCtD
Framycetin—Hypersensitivity—Exemestane—breast cancer	0.000366	0.00462	CcSEcCtD
Framycetin—Vomiting—Fulvestrant—breast cancer	0.000364	0.00459	CcSEcCtD
Framycetin—Vomiting—Toremifene—breast cancer	0.000359	0.00453	CcSEcCtD
Framycetin—Erythema—Goserelin—breast cancer	0.000354	0.00446	CcSEcCtD
Framycetin—Pruritus—Exemestane—breast cancer	0.000352	0.00443	CcSEcCtD
Framycetin—Hypersensitivity—Ixabepilone—breast cancer	0.000346	0.00436	CcSEcCtD
Framycetin—Diarrhoea—Exemestane—breast cancer	0.00034	0.00429	CcSEcCtD
Framycetin—Swelling—Docetaxel—breast cancer	0.00034	0.00429	CcSEcCtD
Framycetin—Nausea—Fulvestrant—breast cancer	0.00034	0.00429	CcSEcCtD
Framycetin—Infection—Chlorambucil—breast cancer	0.000337	0.00425	CcSEcCtD
Framycetin—Nausea—Toremifene—breast cancer	0.000336	0.00423	CcSEcCtD
Framycetin—Pruritus—Ixabepilone—breast cancer	0.000332	0.00418	CcSEcCtD
Framycetin—Swelling—Capecitabine—breast cancer	0.000329	0.00415	CcSEcCtD
Framycetin—Hypersensitivity—Anastrozole—breast cancer	0.000325	0.0041	CcSEcCtD
Framycetin—Diarrhoea—Ixabepilone—breast cancer	0.000321	0.00405	CcSEcCtD
Framycetin—Erythema—Vinorelbine—breast cancer	0.000317	0.00399	CcSEcCtD
Framycetin—Vomiting—Exemestane—breast cancer	0.000316	0.00398	CcSEcCtD
Framycetin—Pruritus—Anastrozole—breast cancer	0.000312	0.00394	CcSEcCtD
Framycetin—Pruritus—Letrozole—breast cancer	0.000312	0.00394	CcSEcCtD
Framycetin—Hypersensitivity—Idarubicin—breast cancer	0.000309	0.00389	CcSEcCtD
Framycetin—Viral infection—Epirubicin—breast cancer	0.000309	0.00389	CcSEcCtD
Framycetin—Erythema—Thiotepa—breast cancer	0.000303	0.00381	CcSEcCtD
Framycetin—Diarrhoea—Anastrozole—breast cancer	0.000302	0.00381	CcSEcCtD
Framycetin—Diarrhoea—Letrozole—breast cancer	0.000302	0.00381	CcSEcCtD
Framycetin—Infection—Tamoxifen—breast cancer	0.0003	0.00379	CcSEcCtD
Framycetin—Vomiting—Ixabepilone—breast cancer	0.000298	0.00376	CcSEcCtD
Framycetin—Anaphylactic shock—Melphalan—breast cancer	0.000296	0.00373	CcSEcCtD
Framycetin—Nausea—Exemestane—breast cancer	0.000295	0.00372	CcSEcCtD
Framycetin—Infection—Melphalan—breast cancer	0.000294	0.00371	CcSEcCtD
Framycetin—Anaphylactic shock—Goserelin—breast cancer	0.000289	0.00364	CcSEcCtD
Framycetin—Diarrhoea—Raloxifene—breast cancer	0.000287	0.00362	CcSEcCtD
Framycetin—Diarrhoea—Idarubicin—breast cancer	0.000287	0.00362	CcSEcCtD
Framycetin—Infection—Goserelin—breast cancer	0.000287	0.00362	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—breast cancer	0.000285	0.0036	CcSEcCtD
Framycetin—Vomiting—Anastrozole—breast cancer	0.000281	0.00354	CcSEcCtD
Framycetin—Vomiting—Letrozole—breast cancer	0.000281	0.00354	CcSEcCtD
Framycetin—Nausea—Ixabepilone—breast cancer	0.000279	0.00351	CcSEcCtD
Framycetin—Vomiting—Raloxifene—breast cancer	0.000267	0.00336	CcSEcCtD
Framycetin—Vomiting—Idarubicin—breast cancer	0.000267	0.00336	CcSEcCtD
Framycetin—Nausea—Letrozole—breast cancer	0.000262	0.00331	CcSEcCtD
Framycetin—Nausea—Anastrozole—breast cancer	0.000262	0.00331	CcSEcCtD
Framycetin—Erythema—Mitoxantrone—breast cancer	0.000261	0.00329	CcSEcCtD
Framycetin—Anaphylactic shock—Vinorelbine—breast cancer	0.000259	0.00326	CcSEcCtD
Framycetin—Infection—Vinorelbine—breast cancer	0.000257	0.00324	CcSEcCtD
Framycetin—Erythema—Gemcitabine—breast cancer	0.000255	0.00321	CcSEcCtD
Framycetin—Erythema—Fluorouracil—breast cancer	0.00025	0.00315	CcSEcCtD
Framycetin—Hypersensitivity—Chlorambucil—breast cancer	0.00025	0.00315	CcSEcCtD
Framycetin—Nausea—Idarubicin—breast cancer	0.000249	0.00314	CcSEcCtD
Framycetin—Nausea—Raloxifene—breast cancer	0.000249	0.00314	CcSEcCtD
Framycetin—Infection—Thiotepa—breast cancer	0.000245	0.00309	CcSEcCtD
Framycetin—Pruritus—Chlorambucil—breast cancer	0.00024	0.00303	CcSEcCtD
Framycetin—Diarrhoea—Chlorambucil—breast cancer	0.000232	0.00293	CcSEcCtD
Framycetin—Hypersensitivity—Vinblastine—breast cancer	0.000229	0.00289	CcSEcCtD
Framycetin—Hypersensitivity—Tamoxifen—breast cancer	0.000223	0.00281	CcSEcCtD
Framycetin—Hypersensitivity—Melphalan—breast cancer	0.000218	0.00275	CcSEcCtD
Framycetin—Vomiting—Chlorambucil—breast cancer	0.000216	0.00272	CcSEcCtD
Framycetin—Pruritus—Tamoxifen—breast cancer	0.000214	0.0027	CcSEcCtD
Framycetin—Anaphylactic shock—Mitoxantrone—breast cancer	0.000213	0.00269	CcSEcCtD
Framycetin—Anaphylactic shock—Irinotecan—breast cancer	0.000213	0.00269	CcSEcCtD
Framycetin—Erythema—Paclitaxel—breast cancer	0.000213	0.00269	CcSEcCtD
Framycetin—Diarrhoea—Vinblastine—breast cancer	0.000213	0.00268	CcSEcCtD
Framycetin—Hypersensitivity—Goserelin—breast cancer	0.000213	0.00268	CcSEcCtD
Framycetin—Infection—Mitoxantrone—breast cancer	0.000212	0.00267	CcSEcCtD
Framycetin—Infection—Irinotecan—breast cancer	0.000212	0.00267	CcSEcCtD
Framycetin—Pruritus—Melphalan—breast cancer	0.000209	0.00264	CcSEcCtD
Framycetin—Anaphylactic shock—Gemcitabine—breast cancer	0.000208	0.00262	CcSEcCtD
Framycetin—Diarrhoea—Tamoxifen—breast cancer	0.000207	0.00261	CcSEcCtD
Framycetin—Infection—Gemcitabine—breast cancer	0.000206	0.0026	CcSEcCtD
Framycetin—Pruritus—Goserelin—breast cancer	0.000204	0.00257	CcSEcCtD
Framycetin—Anaphylactic shock—Fluorouracil—breast cancer	0.000204	0.00257	CcSEcCtD
Framycetin—Infection—Fluorouracil—breast cancer	0.000203	0.00256	CcSEcCtD
Framycetin—Diarrhoea—Melphalan—breast cancer	0.000202	0.00255	CcSEcCtD
Framycetin—Nausea—Chlorambucil—breast cancer	0.000202	0.00254	CcSEcCtD
Framycetin—Vomiting—Vinblastine—breast cancer	0.000198	0.00249	CcSEcCtD
Framycetin—Diarrhoea—Goserelin—breast cancer	0.000198	0.00249	CcSEcCtD
Framycetin—Vomiting—Tamoxifen—breast cancer	0.000192	0.00242	CcSEcCtD
Framycetin—Hypersensitivity—Vinorelbine—breast cancer	0.00019	0.0024	CcSEcCtD
Framycetin—Vomiting—Melphalan—breast cancer	0.000188	0.00237	CcSEcCtD
Framycetin—Nausea—Vinblastine—breast cancer	0.000185	0.00233	CcSEcCtD
Framycetin—Vomiting—Goserelin—breast cancer	0.000184	0.00231	CcSEcCtD
Framycetin—Pruritus—Vinorelbine—breast cancer	0.000183	0.00231	CcSEcCtD
Framycetin—Hypersensitivity—Thiotepa—breast cancer	0.000182	0.00229	CcSEcCtD
Framycetin—Erythema—Docetaxel—breast cancer	0.000181	0.00228	CcSEcCtD
Framycetin—Nausea—Tamoxifen—breast cancer	0.00018	0.00226	CcSEcCtD
Framycetin—Diarrhoea—Vinorelbine—breast cancer	0.000177	0.00223	CcSEcCtD
Framycetin—Nausea—Melphalan—breast cancer	0.000176	0.00222	CcSEcCtD
Framycetin—Erythema—Capecitabine—breast cancer	0.000175	0.0022	CcSEcCtD
Framycetin—Pruritus—Thiotepa—breast cancer	0.000175	0.0022	CcSEcCtD
Framycetin—Anaphylactic shock—Paclitaxel—breast cancer	0.000174	0.00219	CcSEcCtD
Framycetin—Infection—Paclitaxel—breast cancer	0.000173	0.00218	CcSEcCtD
Framycetin—Nausea—Goserelin—breast cancer	0.000171	0.00216	CcSEcCtD
Framycetin—Diarrhoea—Thiotepa—breast cancer	0.000169	0.00213	CcSEcCtD
Framycetin—Vomiting—Vinorelbine—breast cancer	0.000164	0.00207	CcSEcCtD
Framycetin—Hypersensitivity—Mitoxantrone—breast cancer	0.000157	0.00198	CcSEcCtD
Framycetin—Hypersensitivity—Irinotecan—breast cancer	0.000157	0.00198	CcSEcCtD
Framycetin—Vomiting—Thiotepa—breast cancer	0.000157	0.00198	CcSEcCtD
Framycetin—Nausea—Vinorelbine—breast cancer	0.000154	0.00194	CcSEcCtD
Framycetin—Hypersensitivity—Fluorouracil—breast cancer	0.00015	0.0019	CcSEcCtD
Framycetin—Anaphylactic shock—Docetaxel—breast cancer	0.000147	0.00186	CcSEcCtD
Framycetin—Pruritus—Gemcitabine—breast cancer	0.000147	0.00185	CcSEcCtD
Framycetin—Nausea—Thiotepa—breast cancer	0.000147	0.00185	CcSEcCtD
Framycetin—Infection—Docetaxel—breast cancer	0.000146	0.00185	CcSEcCtD
Framycetin—Diarrhoea—Irinotecan—breast cancer	0.000146	0.00184	CcSEcCtD
Framycetin—Diarrhoea—Mitoxantrone—breast cancer	0.000146	0.00184	CcSEcCtD
Framycetin—Pruritus—Fluorouracil—breast cancer	0.000144	0.00182	CcSEcCtD
Framycetin—Diarrhoea—Gemcitabine—breast cancer	0.000142	0.00179	CcSEcCtD
Framycetin—Infection—Capecitabine—breast cancer	0.000142	0.00179	CcSEcCtD
Framycetin—Diarrhoea—Fluorouracil—breast cancer	0.00014	0.00176	CcSEcCtD
Framycetin—Vomiting—Mitoxantrone—breast cancer	0.000136	0.00171	CcSEcCtD
Framycetin—Vomiting—Irinotecan—breast cancer	0.000136	0.00171	CcSEcCtD
Framycetin—Vomiting—Gemcitabine—breast cancer	0.000132	0.00166	CcSEcCtD
Framycetin—Erythema—Methotrexate—breast cancer	0.00013	0.00164	CcSEcCtD
Framycetin—Vomiting—Fluorouracil—breast cancer	0.00013	0.00164	CcSEcCtD
Framycetin—Hypersensitivity—Paclitaxel—breast cancer	0.000128	0.00162	CcSEcCtD
Framycetin—Nausea—Mitoxantrone—breast cancer	0.000127	0.0016	CcSEcCtD
Framycetin—Nausea—Irinotecan—breast cancer	0.000127	0.0016	CcSEcCtD
Framycetin—Nausea—Gemcitabine—breast cancer	0.000123	0.00156	CcSEcCtD
Framycetin—Pruritus—Paclitaxel—breast cancer	0.000123	0.00155	CcSEcCtD
Framycetin—Erythema—Epirubicin—breast cancer	0.000122	0.00154	CcSEcCtD
Framycetin—Nausea—Fluorouracil—breast cancer	0.000121	0.00153	CcSEcCtD
Framycetin—Diarrhoea—Paclitaxel—breast cancer	0.000119	0.0015	CcSEcCtD
Framycetin—Erythema—Doxorubicin—breast cancer	0.000113	0.00142	CcSEcCtD
Framycetin—Vomiting—Paclitaxel—breast cancer	0.000111	0.00139	CcSEcCtD
Framycetin—Hypersensitivity—Docetaxel—breast cancer	0.000109	0.00137	CcSEcCtD
Framycetin—Anaphylactic shock—Methotrexate—breast cancer	0.000106	0.00134	CcSEcCtD
Framycetin—Infection—Methotrexate—breast cancer	0.000106	0.00133	CcSEcCtD
Framycetin—Hypersensitivity—Capecitabine—breast cancer	0.000105	0.00133	CcSEcCtD
Framycetin—Pruritus—Docetaxel—breast cancer	0.000104	0.00131	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL27—breast cancer	0.000103	0.000979	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDE2A—breast cancer	0.000103	0.000979	CbGpPWpGaD
Framycetin—CXCR4—Disease—TLE3—breast cancer	0.000103	0.000979	CbGpPWpGaD
Framycetin—Nausea—Paclitaxel—breast cancer	0.000103	0.0013	CcSEcCtD
Framycetin—CXCR4—Disease—HEY1—breast cancer	0.000102	0.000969	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—EDNRB—breast cancer	0.000102	0.000968	CbGpPWpGaD
Framycetin—Pruritus—Capecitabine—breast cancer	0.000101	0.00127	CcSEcCtD
Framycetin—Diarrhoea—Docetaxel—breast cancer	0.000101	0.00127	CcSEcCtD
Framycetin—CXCR4—Disease—RPL23A—breast cancer	0.0001	0.00095	CbGpPWpGaD
Framycetin—CXCR4—Disease—DLL1—breast cancer	0.0001	0.00095	CbGpPWpGaD
Framycetin—Anaphylactic shock—Epirubicin—breast cancer	9.94e-05	0.00125	CcSEcCtD
Framycetin—Infection—Epirubicin—breast cancer	9.88e-05	0.00125	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—BMPR2—breast cancer	9.87e-05	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DLL4—breast cancer	9.87e-05	0.000934	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIST1H2BC—breast cancer	9.86e-05	0.000933	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIST1H2BK—breast cancer	9.86e-05	0.000933	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAP2K7—breast cancer	9.86e-05	0.000933	CbGpPWpGaD
Framycetin—Diarrhoea—Capecitabine—breast cancer	9.77e-05	0.00123	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CXCL2—breast cancer	9.7e-05	0.000918	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGTR2—breast cancer	9.7e-05	0.000918	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTHLH—breast cancer	9.6e-05	0.000908	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDH5—breast cancer	9.46e-05	0.000895	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—breast cancer	9.37e-05	0.00118	CcSEcCtD
Framycetin—CXCR4—Disease—RPS7—breast cancer	9.37e-05	0.000886	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS8—breast cancer	9.37e-05	0.000886	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CALCA—breast cancer	9.3e-05	0.00088	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDNRB—breast cancer	9.29e-05	0.000879	CbGpPWpGaD
Framycetin—CXCR4—Disease—DKK1—breast cancer	9.29e-05	0.000879	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SFRP2—breast cancer	9.28e-05	0.000878	CbGpPWpGaD
Framycetin—CXCR4—Disease—ALDOA—breast cancer	9.22e-05	0.000872	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—breast cancer	9.2e-05	0.00116	CcSEcCtD
Framycetin—Infection—Doxorubicin—breast cancer	9.14e-05	0.00115	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PRLR—breast cancer	9.11e-05	0.000862	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL12—breast cancer	9.09e-05	0.00086	CbGpPWpGaD
Framycetin—CXCR4—Disease—JAG2—breast cancer	9.08e-05	0.000859	CbGpPWpGaD
Framycetin—Vomiting—Capecitabine—breast cancer	9.07e-05	0.00114	CcSEcCtD
Framycetin—CXCR4—Disease—WNT1—breast cancer	8.95e-05	0.000847	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A2—breast cancer	8.89e-05	0.000841	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GLI2—breast cancer	8.8e-05	0.000832	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VCP—breast cancer	8.8e-05	0.000832	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—breast cancer	8.76e-05	0.0011	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	8.75e-05	0.000828	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTR—breast cancer	8.71e-05	0.000824	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEPR—breast cancer	8.65e-05	0.000819	CbGpPWpGaD
Framycetin—Nausea—Capecitabine—breast cancer	8.48e-05	0.00107	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CALCA—breast cancer	8.45e-05	0.000799	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL12—breast cancer	8.25e-05	0.000781	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AGTR1—breast cancer	8.22e-05	0.000777	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSPA1B—breast cancer	8.09e-05	0.000766	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ARHGDIA—breast cancer	8.05e-05	0.000761	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FST—breast cancer	7.84e-05	0.000742	CbGpPWpGaD
Framycetin—Hypersensitivity—Methotrexate—breast cancer	7.83e-05	0.000987	CcSEcCtD
Framycetin—CXCR4—Disease—ENO1—breast cancer	7.76e-05	0.000734	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HEY2—breast cancer	7.74e-05	0.000733	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RPS6KB2—breast cancer	7.65e-05	0.000724	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RGS2—breast cancer	7.56e-05	0.000716	CbGpPWpGaD
Framycetin—Pruritus—Methotrexate—breast cancer	7.52e-05	0.000948	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL20—breast cancer	7.48e-05	0.000708	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGTR1—breast cancer	7.46e-05	0.000706	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ITPR1—breast cancer	7.37e-05	0.000698	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF3—breast cancer	7.34e-05	0.000694	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—breast cancer	7.33e-05	0.000923	CcSEcCtD
Framycetin—Diarrhoea—Methotrexate—breast cancer	7.27e-05	0.000916	CcSEcCtD
Framycetin—CXCR4—Disease—FASN—breast cancer	7.25e-05	0.000685	CbGpPWpGaD
Framycetin—CXCR4—Disease—JAG1—breast cancer	7.25e-05	0.000685	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LPAR1—breast cancer	7.24e-05	0.000685	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TLE3—breast cancer	7.24e-05	0.000685	CbGpPWpGaD
Framycetin—CXCR4—Disease—PARP1—breast cancer	7.21e-05	0.000683	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HEY1—breast cancer	7.17e-05	0.000678	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALCA—breast cancer	7.13e-05	0.000674	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS6—breast cancer	7.04e-05	0.000666	CbGpPWpGaD
Framycetin—Pruritus—Epirubicin—breast cancer	7.03e-05	0.000887	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—DLL1—breast cancer	7.03e-05	0.000665	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF4—breast cancer	6.99e-05	0.000661	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIST1H2BC—breast cancer	6.9e-05	0.000653	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIST1H2BK—breast cancer	6.9e-05	0.000653	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A1—breast cancer	6.88e-05	0.000651	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDE4D—breast cancer	6.84e-05	0.000647	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRB7—breast cancer	6.84e-05	0.000647	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CSF2—breast cancer	6.81e-05	0.000644	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—breast cancer	6.8e-05	0.000858	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—breast cancer	6.78e-05	0.000854	CcSEcCtD
Framycetin—Vomiting—Methotrexate—breast cancer	6.76e-05	0.000852	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—TAB2—breast cancer	6.72e-05	0.000636	CbGpPWpGaD
Framycetin—CXCR4—Disease—TCF7L2—breast cancer	6.71e-05	0.000635	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ITPR1—breast cancer	6.7e-05	0.000634	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR2—breast cancer	6.67e-05	0.000631	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—breast cancer	6.66e-05	0.00063	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MMP3—breast cancer	6.65e-05	0.000629	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—breast cancer	6.51e-05	0.000821	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—DKK1—breast cancer	6.51e-05	0.000616	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSP90AA1—breast cancer	6.47e-05	0.000612	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFC—breast cancer	6.46e-05	0.000611	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JAG2—breast cancer	6.36e-05	0.000602	CbGpPWpGaD
Framycetin—Vomiting—Epirubicin—breast cancer	6.32e-05	0.000797	CcSEcCtD
Framycetin—Nausea—Methotrexate—breast cancer	6.31e-05	0.000796	CcSEcCtD
Framycetin—CXCR4—Disease—PRL—breast cancer	6.29e-05	0.000596	CbGpPWpGaD
Framycetin—Diarrhoea—Doxorubicin—breast cancer	6.29e-05	0.000794	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—WNT1—breast cancer	6.27e-05	0.000593	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PLA2G4A—breast cancer	6.25e-05	0.000592	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADAM10—breast cancer	6.2e-05	0.000587	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CSF2—breast cancer	6.18e-05	0.000585	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF10—breast cancer	6.04e-05	0.000571	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH4—breast cancer	5.94e-05	0.000562	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—breast cancer	5.91e-05	0.000745	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GZMB—breast cancer	5.91e-05	0.000559	CbGpPWpGaD
Framycetin—Vomiting—Doxorubicin—breast cancer	5.85e-05	0.000737	CcSEcCtD
Framycetin—CXCR4—Disease—PDGFA—breast cancer	5.82e-05	0.000551	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFBR2—breast cancer	5.74e-05	0.000543	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL2—breast cancer	5.73e-05	0.000542	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR2—breast cancer	5.73e-05	0.000542	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BMP2—breast cancer	5.67e-05	0.000536	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTHLH—breast cancer	5.67e-05	0.000536	CbGpPWpGaD
Framycetin—CXCR4—Disease—ITPR1—breast cancer	5.65e-05	0.000534	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT5A—breast cancer	5.61e-05	0.000531	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB4—breast cancer	5.61e-05	0.000531	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDNRB—breast cancer	5.49e-05	0.000519	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—breast cancer	5.46e-05	0.000689	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PGR—breast cancer	5.43e-05	0.000514	CbGpPWpGaD
Framycetin—CXCR4—Disease—SMAD4—breast cancer	5.43e-05	0.000514	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—THBS1—breast cancer	5.41e-05	0.000512	CbGpPWpGaD
Framycetin—CXCR4—Disease—HES1—breast cancer	5.31e-05	0.000502	CbGpPWpGaD
Framycetin—CXCR4—Disease—NCOR1—breast cancer	5.28e-05	0.000499	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF1—breast cancer	5.22e-05	0.000494	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRG1—breast cancer	5.18e-05	0.00049	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FLT1—breast cancer	5.16e-05	0.000488	CbGpPWpGaD
Framycetin—CXCR4—Disease—H2AFX—breast cancer	5.14e-05	0.000486	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF3—breast cancer	5.14e-05	0.000486	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SQSTM1—breast cancer	5.14e-05	0.000486	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—breast cancer	5.11e-05	0.000484	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JAG1—breast cancer	5.07e-05	0.00048	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH3—breast cancer	5.05e-05	0.000478	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PARP1—breast cancer	5.05e-05	0.000478	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALCA—breast cancer	4.99e-05	0.000472	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERCC2—breast cancer	4.96e-05	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RPS6—breast cancer	4.93e-05	0.000467	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF4—breast cancer	4.89e-05	0.000463	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL12—breast cancer	4.87e-05	0.000461	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB3—breast cancer	4.85e-05	0.000459	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR2—breast cancer	4.84e-05	0.000458	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PAK1—breast cancer	4.78e-05	0.000453	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TCF7L2—breast cancer	4.7e-05	0.000445	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT2—breast cancer	4.68e-05	0.000443	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—breast cancer	4.66e-05	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—breast cancer	4.65e-05	0.00044	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—breast cancer	4.64e-05	0.000439	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSP90AA1—breast cancer	4.53e-05	0.000429	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH2—breast cancer	4.53e-05	0.000429	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR1—breast cancer	4.51e-05	0.000427	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—breast cancer	4.5e-05	0.000425	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—breast cancer	4.45e-05	0.000421	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR1—breast cancer	4.41e-05	0.000417	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRL—breast cancer	4.41e-05	0.000417	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STK11—breast cancer	4.34e-05	0.000411	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADAM10—breast cancer	4.34e-05	0.000411	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—breast cancer	4.3e-05	0.000407	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLG—breast cancer	4.3e-05	0.000406	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT2—breast cancer	4.25e-05	0.000402	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF10—breast cancer	4.23e-05	0.0004	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—breast cancer	4.08e-05	0.000386	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFA—breast cancer	4.08e-05	0.000386	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—breast cancer	4.04e-05	0.000383	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFBR2—breast cancer	4.02e-05	0.00038	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOTCH1—breast cancer	4.01e-05	0.000379	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITPR1—breast cancer	3.96e-05	0.000374	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB4—breast cancer	3.93e-05	0.000372	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP3—breast cancer	3.93e-05	0.000372	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT5A—breast cancer	3.93e-05	0.000372	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—breast cancer	3.92e-05	0.000371	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—breast cancer	3.92e-05	0.000371	CbGpPWpGaD
Framycetin—CXCR4—Disease—KIT—breast cancer	3.92e-05	0.000371	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGF—breast cancer	3.87e-05	0.000366	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SMAD4—breast cancer	3.81e-05	0.00036	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1R—breast cancer	3.78e-05	0.000358	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—breast cancer	3.77e-05	0.000356	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HES1—breast cancer	3.72e-05	0.000352	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCOR1—breast cancer	3.69e-05	0.00035	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLA2G4A—breast cancer	3.69e-05	0.00035	CbGpPWpGaD
Framycetin—CXCR4—Disease—BRAF—breast cancer	3.68e-05	0.000348	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF1—breast cancer	3.65e-05	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CSF2—breast cancer	3.65e-05	0.000346	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RAF1—breast cancer	3.64e-05	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRG1—breast cancer	3.63e-05	0.000343	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—H2AFX—breast cancer	3.6e-05	0.000341	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—breast cancer	3.6e-05	0.00034	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT2—breast cancer	3.58e-05	0.000339	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—E2F1—breast cancer	3.57e-05	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—breast cancer	3.56e-05	0.000337	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CD—breast cancer	3.44e-05	0.000326	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—breast cancer	3.43e-05	0.000325	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—breast cancer	3.42e-05	0.000324	CbGpPWpGaD
Framycetin—CXCR4—Disease—SERPINE1—breast cancer	3.41e-05	0.000322	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB3—breast cancer	3.4e-05	0.000321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR2—breast cancer	3.39e-05	0.000321	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—breast cancer	3.27e-05	0.000309	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TERT—breast cancer	3.26e-05	0.000308	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—breast cancer	3.25e-05	0.000308	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR1—breast cancer	3.16e-05	0.000299	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—breast cancer	3.11e-05	0.000295	CbGpPWpGaD
Framycetin—CXCR4—Disease—MDM2—breast cancer	3.08e-05	0.000292	CbGpPWpGaD
Framycetin—CXCR4—Disease—RAF1—breast cancer	3.07e-05	0.000291	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—breast cancer	3.04e-05	0.000288	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—breast cancer	3.04e-05	0.000288	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—breast cancer	3.01e-05	0.000285	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—breast cancer	3e-05	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—breast cancer	3e-05	0.000284	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—breast cancer	3e-05	0.000283	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—breast cancer	2.98e-05	0.000282	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—breast cancer	2.97e-05	0.000281	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ESR1—breast cancer	2.9e-05	0.000275	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FN1—breast cancer	2.87e-05	0.000271	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKBIA—breast cancer	2.83e-05	0.000268	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—breast cancer	2.82e-05	0.000267	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH1—breast cancer	2.8e-05	0.000265	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KIT—breast cancer	2.74e-05	0.00026	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—breast cancer	2.74e-05	0.00026	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—breast cancer	2.74e-05	0.00026	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGF—breast cancer	2.71e-05	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—breast cancer	2.66e-05	0.000252	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—breast cancer	2.63e-05	0.000249	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—breast cancer	2.6e-05	0.000246	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—breast cancer	2.59e-05	0.000245	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BRAF—breast cancer	2.58e-05	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—breast cancer	2.51e-05	0.000238	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT2—breast cancer	2.51e-05	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—breast cancer	2.5e-05	0.000236	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—breast cancer	2.41e-05	0.000228	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—breast cancer	2.41e-05	0.000228	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—breast cancer	2.39e-05	0.000226	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SERPINE1—breast cancer	2.38e-05	0.000226	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—breast cancer	2.36e-05	0.000223	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—breast cancer	2.32e-05	0.000219	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—breast cancer	2.28e-05	0.000215	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—breast cancer	2.22e-05	0.00021	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—breast cancer	2.17e-05	0.000205	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MDM2—breast cancer	2.16e-05	0.000204	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—breast cancer	2.16e-05	0.000204	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RAF1—breast cancer	2.15e-05	0.000204	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—breast cancer	2.15e-05	0.000203	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RELA—breast cancer	2.14e-05	0.000203	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—breast cancer	2.13e-05	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—breast cancer	2.11e-05	0.000199	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—breast cancer	2.1e-05	0.000199	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—breast cancer	2.1e-05	0.000199	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—breast cancer	2.02e-05	0.000191	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—breast cancer	2.01e-05	0.00019	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—breast cancer	1.99e-05	0.000188	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—breast cancer	1.97e-05	0.000187	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—breast cancer	1.95e-05	0.000185	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—breast cancer	1.93e-05	0.000183	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—breast cancer	1.93e-05	0.000183	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—breast cancer	1.92e-05	0.000182	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—breast cancer	1.88e-05	0.000178	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—breast cancer	1.88e-05	0.000178	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—breast cancer	1.86e-05	0.000176	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—breast cancer	1.83e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—breast cancer	1.83e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—breast cancer	1.82e-05	0.000172	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—breast cancer	1.82e-05	0.000172	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—breast cancer	1.78e-05	0.000168	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—breast cancer	1.77e-05	0.000168	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—breast cancer	1.69e-05	0.00016	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—breast cancer	1.68e-05	0.000159	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—breast cancer	1.64e-05	0.000155	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—breast cancer	1.62e-05	0.000154	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—breast cancer	1.62e-05	0.000153	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—breast cancer	1.55e-05	0.000147	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—breast cancer	1.51e-05	0.000143	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—breast cancer	1.51e-05	0.000142	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—breast cancer	1.49e-05	0.000141	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—breast cancer	1.48e-05	0.00014	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—breast cancer	1.39e-05	0.000132	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—breast cancer	1.28e-05	0.000121	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—breast cancer	1.24e-05	0.000117	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—breast cancer	1.19e-05	0.000112	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—breast cancer	1.13e-05	0.000107	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—breast cancer	1.05e-05	9.9e-05	CbGpPWpGaD
